ARCHIVES

FDA Advisors Discuses Establishment of Standards for Showing Equivalence

This article is from The Cancer Letter archive.

Vol. 25 No. 48 | December 17, 1999

Download PDF Visit The Full Archive

Related Articles

Komen Foundation Shifts Emphasis To Underserved

May 7, 1993

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

April 28, 2006

Feinstein Reintroduces New National Cancer Act

June 13, 2003

As Leadership Changes Continue, Fontaine, Leach Get New Posts

January 17, 2014

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

August 2, 1991

Program Project Guidelines Listed

March 18, 1977